John L Stanford

Title: John L Stanford: Innovator in Immunology

Introduction

John L Stanford is a notable inventor based in Great Britain, recognized for his contributions to the field of immunology. He has focused on the therapeutic applications of Mycobacterium vaccae, particularly in the treatment of uveitis. Although he holds no patents, his research has significant implications for medical science.

Latest Patents

Stanford's latest patents include "Mycobacterium Vaccae In The Treatment Of Uveitis," which discusses the use of antigenic or immunoregulatory material derived from Mycobacterium vaccae in the manufacture of a therapeutic agent for the treatment of uveitis. The patent specifies that the M. vaccae is preferably in the form of dead cells, ideally prepared by autoclaving. The therapeutic agent is designed to contain, per dose, antigenic or immunoregulatory material from 10⁷ to 10¹⁰ M. vaccae microorganisms. Another patent, "Mycobacterium As Adjuvant For Antigens," highlights the use of immunoregulatory material from a mycobacterium other than M. tuberculosis, particularly killed cells of M. vaccae, as an advantageous adjuvant for administration with antigens, including allergens.

Career Highlights

Throughout his career, John L Stanford has worked with prestigious institutions, including University College London and Stanford Rook Limited. His work has contributed to advancements in immunological research and therapeutic applications.

Collaborations

Stanford has collaborated with notable individuals in his field, including Graham A Rook and Graham Aw Rook. These collaborations have furthered his research and development efforts in immunology.

Conclusion

John L Stanford's innovative work in the field of immunology, particularly regarding Mycobacterium vaccae, showcases his commitment to advancing medical science. His research has the potential to impact therapeutic approaches for various conditions, including uveitis.